AN
38
-2
SWKS
46
3
TJX
50
2
PLD
45
8
ETR
66
-2
HAS
42
-2
ADI
52
-2
CFG
58
2
MMM
56
-3
PYPL
31
-2
ALLE
35
3
WDC
40
2
CINF
53
-3
LLY
57
3
CMG
43
-4
TGNA
72
5
MUR
38
-4
WY
47
-3
DLTR
40
-3
MDLZ
53
-2
AN
38
-2
SWKS
46
3
TJX
50
2
PLD
45
8
ETR
66
-2
HAS
42
-2
ADI
52
-2
CFG
58
2
MMM
56
-3
PYPL
31
-2
ALLE
35
3
WDC
40
2
CINF
53
-3
LLY
57
3
CMG
43
-4
TGNA
72
5
MUR
38
-4
WY
47
-3
DLTR
40
-3
MDLZ
53
-2
Financhill
Back

SPDR S&P Pharmaceuticals ETF Stock Predictions

Economy going through a "period of transition" - Your portfolio doesn't have to

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34

XPH
SPDR S&P Pharmaceuticals ETF

Last Price:
$44.05
Seasonality Move:
1.16%

7 Day Trial

ALL ACCESS PASS

$ 7

The Tariff-Proof Asset in Your Pocket

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

SPDR S&P Pharmaceuticals ETF Stock Forecast

  • Over the next 52 weeks, SPDR S&P Pharmaceuticals ETF has on average historically risen by 8.3% based on the past 18 years of stock performance.
  • SPDR S&P Pharmaceuticals ETF has risen higher in 12 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is SPDR S&P Pharmaceuticals ETF Stock Undervalued?
    The current SPDR S&P Pharmaceuticals ETF [XPH] share price is $43.71. The Score for XPH is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • XPH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will SPDR S&P Pharmaceuticals ETF Stock Go Up Next Year?

  • Over the next 52 weeks, SPDR S&P Pharmaceuticals ETF has on average historically risen by 8.3% based on the past 18 years of stock performance.

SPDR S&P Pharmaceuticals ETF Stock Rating

Sell
34
SPDR S&P Pharmaceuticals ETF (XPH) is a Sell

Is SPDR S&P Pharmaceuticals ETF overpriced?

  • SPDR S&P Pharmaceuticals ETF has risen higher in 12 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

SPDR S&P Pharmaceuticals ETF Stock Price History

Is XPH stock going to rise?

  • The current trend is relatively stagnant and XPH is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
48.76
52-Week Low:
38.88

Prediction Charts

Market Cap:
0
Price in USD:
43.71
Volume:
27.3K
Beta:
0.80

Technical Analysis

SMA50:
44.25
SMA100:
44.95
SMA200:
43.73
52-Wk Change:
3.82%

Stock Predictions

  • Is SPDR S&P Pharmaceuticals ETF stock public?
    Yes, SPDR S&P Pharmaceuticals ETF is a publicly traded company.
  • What is the SPDR S&P Pharmaceuticals ETF stock quote today?
    The SPDR S&P Pharmaceuticals ETF stock price is 43.71 USD today.
  • How to buy SPDR S&P Pharmaceuticals ETF stock online?
    You can buy SPDR S&P Pharmaceuticals ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-26 44.50 44.31 44.99 44.16
Feb-27 44.07 43.84 44.49 43.84
Feb-28 44.05 44.56 44.64 44.00
Mar-3 44.83 43.72 44.89 43.57
Mar-4 43.47 43.76 44.18 43.45
Mar-5 43.83 44.19 44.26 43.69
Mar-6 43.74 44.09 44.43 43.74
Mar-7 44.14 44.43 44.76 44.08
Mar-11 43.55 43.38 43.55 42.90
Mar-12 43.50 43.12 43.62 42.98
Mar-13 43.11 42.59 43.23 42.48
Mar-14 42.81 42.95 43.00 42.68
Mar-17 42.92 43.71 43.84 42.92
Mar-18 43.80 43.71 43.92 43.58

SPDR S&P Pharmaceuticals ETF Earnings

Data Unavailable

SPDR S&P Pharmaceuticals ETF Forecast Revenue Growth

Data Unavailable

* SPDR S&P Pharmaceuticals ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.